11.11.2021 • NewsMilliporeSigmaMerck

MilliporeSigma to Help SaudiVax with Halal Vaccine

MilliporeSigma, part of the German Merck group, has agreed to provide CDMO services for SaudiVax. The Merck offshoot will design a multi-modality manufacturing plant for the Saudi company, which is pursuing the development and manufacture of halal biotherapeutics and vaccines. Financial terms of the arrangement have not been disclosed.

SaudiVax, which is considered to be the first vaccine biotech in the Kingdom, is also poised to become its first developer and manufacturer of halal vaccines and biotherapeutics. Initially, it hopes to turn out 5 to 7 million doses per year.

The production base for the vaccines will be located at the King Abdullah University of Science and Technology (KAUST) campus, north of Jedda, and output will be earmarked for the Middle East and North Africa (MENA) region. According to reports, the facility is expected to be operational by 2023, with fill & finish to start in March of that year and API manufacturing in December.

In a three-phase process, Merck will train SaudiVax employees at its M Lab collaboration center in Molsheim, France, and its end-to-end facility in Martillac, France. The first phase will focus on equipment without attention to the process or GMP conditions. The second will include the full process training in non-GMP conditions in one of the German company’s pilot labs, with the final phase to include training under GMP conditions.

The German group’s task will be finding a replacement for porcine gelatin, which is used as a stabilizer in the production of various vaccines, including the nasal flu vaccine, measles, mumps, and rubella vaccine (MMRVaxPro), as well as the shingles vaccine and some chickenpox vaccines. Questions have been raised in the Middle East as to whether the vaccines are halal (accepted under Islamic law).

Sebastien Ribault, head of end-to-end CDMO Services at Merck, told Bioprocess International Magazine that the manufacturing process for vaccines will be the same as that for other products, with particular attention paid to raw materials and components to make sure they conform to the halal principles.

Author: Dede Williams, Freelance Journalist

MilliporeSigma, part Germany’s Merck, will provide CDMO services for...
MilliporeSigma, part Germany’s Merck, will provide CDMO services for SaudiVax, believed to be Saudi Arabia’s first vacccine biotech. Its task will be to design a multi-modality manufacturing plant in which the company can develop and manufacture halal biotherapeutics and vaccines. (c) SaudiVax

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
19.05.2025 • NewsChemie

OQ Chemicals firmiert künftig wieder als Oxea

Der bis Mai 2020 unter dem Namen Oxea bekannte Hersteller von Oxo-Zwischenprodukten und Oxo-Derivaten, der zwischenzeitlich zum Omanischen Energieunternehmen OQ gehörte und unter dem Namen OQ Chemicals firmierte, kehrt zu seinem alten Namen und seinen Wurzeln zurück.

Photo
08.08.2025 • News

Carbios und Indorama kooperieren bei rPET

Carbios wird recycelte Monomere bereitstellen, die von Indorama Ventures zu Filamenten für die Verstärkung von Reifen des Herstellers Michelin verarbeitet werden.